Floaters and the quality of life
- PMID: 21703388
- DOI: 10.1016/j.ajo.2011.02.015
Floaters and the quality of life
Comment on
-
Utility values associated with vitreous floaters.Am J Ophthalmol. 2011 Jul;152(1):60-65.e1. doi: 10.1016/j.ajo.2011.01.026. Epub 2011 May 12. Am J Ophthalmol. 2011. PMID: 21570045
Similar articles
-
Ultrasound-based quantification of vitreous floaters correlates with contrast sensitivity and quality of life.Invest Ophthalmol Vis Sci. 2015 Jan 22;56(3):1611-7. doi: 10.1167/iovs.14-15414. Invest Ophthalmol Vis Sci. 2015. PMID: 25613948 Free PMC article.
-
Utility values associated with vitreous floaters.Am J Ophthalmol. 2011 Jul;152(1):60-65.e1. doi: 10.1016/j.ajo.2011.01.026. Epub 2011 May 12. Am J Ophthalmol. 2011. PMID: 21570045
-
Vitrectomy for primary symptomatic vitreous opacities: an evidence-based review.Eye (Lond). 2016 May;30(5):645-55. doi: 10.1038/eye.2016.30. Epub 2016 Mar 4. Eye (Lond). 2016. PMID: 26939559 Free PMC article. Review.
-
[Introduction to the topic: quality of life in ophthalmology].Ophthalmologe. 2008 Aug;105(8):721. doi: 10.1007/s00347-008-1803-2. Ophthalmologe. 2008. PMID: 18607600 German. No abstract available.
-
Current treatment for vitreous floaters.Optometry. 2010 Mar;81(3):157-61. doi: 10.1016/j.optm.2009.09.018. Optometry. 2010. PMID: 20211446 Review.
Cited by
-
Ultrasound-based quantification of vitreous floaters correlates with contrast sensitivity and quality of life.Invest Ophthalmol Vis Sci. 2015 Jan 22;56(3):1611-7. doi: 10.1167/iovs.14-15414. Invest Ophthalmol Vis Sci. 2015. PMID: 25613948 Free PMC article.
-
A New Pharmacological Vitreolysis through the Supplement of Mixed Fruit Enzymes for Patients with Ocular Floaters or Vitreous Hemorrhage-Induced Floaters.J Clin Med. 2022 Nov 13;11(22):6710. doi: 10.3390/jcm11226710. J Clin Med. 2022. PMID: 36431188 Free PMC article.
-
The impact of persistent visually disabling vitreous floaters on health status utility values.Qual Life Res. 2013 Aug;22(6):1507-14. doi: 10.1007/s11136-012-0256-x. Epub 2012 Oct 11. Qual Life Res. 2013. PMID: 23054488
-
The Efficacy and Safety of YAG Laser Vitreolysis for Symptomatic Vitreous Floaters of Complete PVD or Non-PVD.Ophthalmol Ther. 2022 Feb;11(1):201-214. doi: 10.1007/s40123-021-00422-6. Epub 2021 Nov 15. Ophthalmol Ther. 2022. PMID: 34778916 Free PMC article.
-
Prevalence of vitreous floaters in a community sample of smartphone users.Int J Ophthalmol. 2013 Jun 18;6(3):402-5. doi: 10.3980/j.issn.2222-3959.2013.03.27. Print 2013. Int J Ophthalmol. 2013. PMID: 23826541 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical